Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

591.00p
   
  • Change Today:
      21.00p
  • 52 Week High: 591.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 120.18m
  • Volume: 230,947
  • Market Cap: £710.28m
  • RiskGrade: 125

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest ShareCast News

RBC Capital Markets raises target price on OXB

By Iain Gilbert

Date: Tuesday 26 Aug 2025

(Sharecast News) - Analysts at RBC Capital Markets hiked their target price on gene and cell therapy firm OXB from 800p to 930p on Tuesday following its recent oversubscribed £60m equity funding and revenue guidance reiteration.

OXB Regulatory News

Total Voting Rights 01-Sep-2025 07:00 RNS
PDMR Dealings 22-Aug-2025 15:36 RNS
Holding(s) in Company 21-Aug-2025 10:24 RNS
Admission of Shares and Total Voting Rights 20-Aug-2025 07:00 RNS
PDMR Dealings 15-Aug-2025 13:45 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 591.00p
Change Today 21.00p
% Change 3.68 %
52 Week High 591.00p
52 Week Low 232.50p
Volume 230,947
Shares Issued 120.18m
Market Cap £710.28m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 05-Sep-2025

Time Volume / Share Price
15:36 2 @ 585.00p
16:47 1,812 @ 583.54p
16:35 63,672 @ 591.00p
16:35 371 @ 591.00p
16:35 192 @ 591.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page